4D Molecular Therapeutics, Inc. ($FDMT)
Filing Information
| Accession Number | 0001193125-26-426810 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
4,905
Total Value
$27,762.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Oct 16, 2026 | Exercise/Conversion | 1,635 | $4.14 | $6,768.90 | 10,252 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Oct 16, 2026 | Sale | 1,635 | $12.84 | $20,993.40 | 8,617 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Oct 16, 2026 | Exercise/Conversion | 1,635 | $0.00 | $0.00 | 56,431 | Direct | โ | View Details |